Search results
Results from the WOW.Com Content Network
Bimagrumab, an experimental drug, works by inhibiting the action of myostatin, which limits the size of skeletal muscle. The drug has shown the ability to increase lean mass simultaneously to decreasing fat mass in obese humans, which is beneficial because it preserves or increases energy expenditure while reducing risks associated with excess fat.
Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake.
Lipase inhibitors may affect the amount of fat absorbed, yet they do not block the absorption of a particular type of fat. [1] Likewise, lipase inhibitors are not absorbed into the bloodstream. Lipase inhibitors bind to lipase enzymes in the intestine, [2] thus preventing the hydrolysis of dietary triglycerides into monoglycerides and fatty ...
Holst, along with others, said a better measure of obesity might be the simple use of a tape measure to check your waist-to-hip ratio, which can assess visceral fat, in addition to body mass index ...
One thing is for sure: You don’t need to suffer just to receive the benefits of the drug. “Ultimately, we're prescribing these medications to improve people’s lives,” Dr. Russo says.
A daily weight loss pill from Novo Nordisk was shown to lower body weight by up to 13% after three months in a Phase 1 clinical trial, according to findings presented Tuesday at the European ...
Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity.
Due to this, the absorption of fat-soluble vitamins may decrease. Therefore, it is recommended to take a multiple-vitamin supplement during orlistat therapy. [9] [12] Cetilistat, a new lipase inhibitor, is an experimental drug for obesity. In October 2016 the drug was still in clinical trials. [13]